7,378
Views
9
CrossRef citations to date
0
Altmetric
LETTERS TO THE EDITOR: CLINICAL ONCOLOGY

Hepatotoxicity associated with ribociclib among breast cancer patients

, &
Pages 195-198 | Received 07 Oct 2020, Accepted 14 Nov 2020, Published online: 04 Dec 2020
 

Disclosure statement

The authors report no conflicts of interest.

Informed consent

Patients gave written consent to the inclusion of material pertaining to themselves, and it was acknowledged that they cannot be identified via the article; and they have been fully anonymized.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.